Funded Tech Companies
EnClear Therapies
Wondering who provided funding to EnClear Therapies? Amgen Ventures, Founders Fund and The Sontag Foundation invested in this innovative medical devices company.
Company Overview
Company Name
EnClear Therapies
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
65 Parker St. 3A.
Newburyport, MA 01950
USA
Newburyport, MA 01950
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
EnClear Therapies was conceived by the founders of QurAlis and Q-State Bio, with the sole purpose of developing novel device-based therapies to treat patients with neurodegenerative disease. The companies first products will aim to halt the progression of ALS and PSP.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/4/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Jonathan Fleming
Chief Executive Officer
Anthony DePasqua
Chief Medical Officer
William Gormley
Chief Scientific Officer
Kasper Roet
Co-Founder
Kevin Eggan
VP - R & D
Kevin Kalish
VP - R & D
William Siopes
Company Investors
- Amgen Ventures
- Founders Fund
- The Sontag Foundation
- Tachyon Ventures
- Bioverge
- Global Health Sciences Fund
- 20/20 HealthCare Partners (Hillel Bachrach)
- Presight Capital
- Private Investors (Peter Thiel)
- Dolby Family Ventures
- Sanford Biosciences
- Thiel Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs